Technovalia is a privately owned early-stage Australian biotech company dedicated to the research and development of innovative vaccines and diagnostics. Technovalia, in partnership with several academic organisations and international companies is investing in the development of new technology platforms having the potential to significantly improve protection against a number of infectious diseases by producing safer, more stable, and more cost-effective vaccines and diagnostic tests. Contact: info@technovalia.com
| Website | http://www.technovalia.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2015 |
| Address | Eastern Innovation Business Centre, 5a Hartnett Close, Mulgrave, Victoria 3170, AU |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research, R&D, Vaccines, Tech Transfer |
| Keywords | Vaccine Research, Vaccine Development, Diagnostic Development, Biotechnology, Immunology, Therapeutics, Drug Discovery, Biotech Research, Life Sciences, Pharmaceutical Research, Medical Technology, Clinical Trials, In Vitro Diagnostics, Molecular Diagnostics, Antibody Development, Biopharmaceutical, Health Technology, Scientific Research, Early Stage Biotech |
Looking for a particular Technovalia employee's phone or email?
Technovalia Questions
Laurent Dapremont is the CEO of Technovalia.
1 people are employed at Technovalia.
Technovalia is based in Mulgrave, Victoria.
Top Technovalia Employees
-
Laurent Dapremont
CEO at Technovalia
Beaumaris, VIC, AU24
Related Companies
